Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor

https://doi.org/10.1016/0922-4106(94)90124-4Get rights and content

Abstract

The amino acid sequence of the rat adenosine A2A receptor and the atomic coordinates of bacteriorhodopsin were combined to generate a three-dimensional model for the adenosine A2A receptor. This model consists of seven amphipathic α-helices, forming a pore that is rather hydrophilic compared to the hydrophobic outside of the protein. Subsequently, a highly potent and selective ligand for this receptor, 2-(cyclohexylmethylidinehydrazino)adenosine (SHA 174), was docked into this cavity. A binding site is proposed that takes into account the conformational characteristics of the ligand. Moreover, it involves two histidine residues that were shown to be important for ligand coordination from chemical modification studies. Subsequently, the deduced binding site was used to model other potent ligands, including 8-(3-chlorostyryl)caffeine, a new A2-selective antagonist, that could all be accomodated consistent with earlier biochemical and pharmacological findings. Finally, some thoughts on how adenosine receptor activation might proceed are put forward, based on structural analogies with the enzyme family of serine proteases.

References (41)

  • F.H. Allen et al.

    The Cambridge Crystallographic Data Base

    Acta Crystallogr.

    (1979)
  • G. Allende et al.

    Role of histidine residues in agonist and antagonist binding sites of A1 adenosine receptor

    J. Neurochem.

    (1993)
  • J.M. Baldwin

    The probable arrangement of the helices in G protein-coupled receptors

    EMBO J.

    (1993)
  • M. Beinborn et al.

    A single amino acid of the cholecystokinin-B / gastrin receptor determines specificity for non-peptide antagonists

    Nature

    (1993)
  • L.E. Brackett et al.

    Functional characterization of the A2B adenosine receptor in NIH 3T3 fibroblasts

    Biochem. Pharmacol.

    (1994)
  • C. Branden et al.

    Introduction to protein structure

  • A.J. Bridges et al.

    N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptor

    J. Med. Chem.

    (1988)
  • D.W. Christianson et al.

    Another catalytic triad?

    Nature

    (1990)
  • J. Devereux et al.

    A comprehensive set of sequence analysis programs for the VAX

    Nucleic Acids Res.

    (1984)
  • J.E. Francis et al.

    Highly selective adenosine A2 receptor agonists in a series of N-alkylated 2-aminoadenosines

    J. Med. Chem.

    (1991)
  • Cited by (47)

    • Alkylation of sulfhydryl groups on Gα<inf>s/olf</inf> subunits by N-ethylmaleimide: Regulation by guanine nucleotides

      2003, Biochimica et Biophysica Acta - Biomembranes
      Citation Excerpt :

      Similar to other GPCRs, adenosine receptors have the characteristic secondary structure of seven α-helical membrane spanning domains connected by three extra- and intracellular loops, respectively. Sequence analysis of A2A adenosine receptors from various species has shown that this receptor subtype is particularly rich in cysteine residues in the extracellular loops and transmembrane domains [9,10]. Some of the cysteine residues in the extracellular loops may form disulfide bridges stabilizing receptor structural features [11,12].

    • Site-directed mutagenesis studies of human A(2A) adenosine receptorsInvolvement of glu<sup>13</sup> and his<sup>278</sup> in ligand binding and sodium modulation

      2000, Biochemical Pharmacology
      Citation Excerpt :

      In the present study, the interactions between the human A2A adenosine receptor and its ligands were investigated by site-directed mutagenesis. In a previous molecular modeling study [17], it had been suggested that a glutamic acid in the first transmembrane domain (Glu13) and a histidine in the seventh transmembrane domain (His278) are somehow linked and that they are involved in agonist binding to the A2A adenosine receptor and its ligands. We followed up on this study by analyzing the binding behavior of the wild-type and the E13Q and H278Y receptors to agonists and antagonists under various conditions.

    View all citing articles on Scopus

    The previous paper in this series appeared in Drug Design and Discovery 9, 49–67 (1992).

    View full text